Category: Forbes

A new study found a nearly 50% increased risk of dementia among patients who had used popular anticholinergic drugs for at least three years, but there’s some good news as well.

The ability of present-day machines to perceive and interpret visual information with astounding accuracy gives us a glimpse of the future of computer vision, where such systems will be able to solve even the most complex visual problems, far surpassin…

Rite Aid losses hit nearly $100 million in the company’s first quarter as the struggling retailer faces reimbursement pressures amid a search for a new CEO.

The November election in San Francisco could include a Juul-sponsored ballot measure that would nix the vaping ban.

The following seven dividend stocks have strong business models, durable competitive advantages, and high dividend yields above 5% that make them extremely attractive stocks for retirees, says Ben Reynolds, a contributor to MoneyShow.com, an income exp…

Are you considering genetic testing? Consider your insurance options first.

Would you replace your meals with pills if you could lose significant weight by doing so? With an estimated 40% of Americans overweight, the weight loss market is projected to be a $253 billion dollar market by 2024. Meet the latest meal replacement te…

Lyft’s Arizona Medicaid relationship offers a glimpse into the expanding opportunities for ride sharing companies including rival Uber as they expand into non-emergency medical transportation services.

The freelance revolution is alive and well, and growing nicely in medicine. Learn how the gig mindset and organizations like OBHG are helping doctors find a more satisfying career.

Measuring health care quality isn’t nearly as straightforward as many think it is. I offer perspective on some of the gaps in current approaches to measuring healthcare quality.